深層腦部刺激器市場規模、佔有率、成長分析（按產品類型、應用、最終用戶和地區）- 產業預測，2025 年至 2032 年

預計全球深部腦部刺激 (DBS) 設備市場規模在 2023 年將達到 15.4 億美元，並從 2024 年的 16.8 億美元成長到 2032 年的 34 億美元，預測期內（2025-2032 年）的複合年成長率為 9.2%。

全球深部腦部刺激設備市場正在經歷強勁成長，這得益於帕金森氏症和自發性震顫等神經系統疾病的發病率不斷上升，從而增加了對有效治療解決方案的需求。 DBS 技術的進步，包括使用壽命更長的可充電設備和改進的瞄準系統，提高了該程序的有效性和安全性。 DBS 作為一種可靠的治療方法越來越受到認可，患者和醫療專業人士的認知度不斷提高，也為市場擴張做出了巨大貢獻。已開發地區優惠的報銷政策和新興市場不斷成長的醫療保健投資進一步推動了製造商的成長機會。總體而言，這些因素的整合可能在未來幾年內顯著推動 DBS 設備市場的發展。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術分析
• 監管分析

深層腦部刺激器市場規模（依產品類型）

• 市場概況
• 單通道 DBS 設備
• 雙通道DBS設備

深層腦部刺激器市場規模（依應用）

• 市場概況
• 癲癇
• 疼痛管理
• 自發性震顫
• 強迫性精神官能症(OCD)
• 帕金森氏症
• 憂鬱症
• 肌張力不全症
• 其他

深層腦部刺激器市場規模（依最終用戶分類）

• 市場概況
• 醫院
• 神經科診所
• 門診手術中心
• 研究中心
• 其他

深層腦部刺激器市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Medtronic Plc.（USA）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Aleva Neurotherapeutics SA（Switzerland）
• Beijing PINS Medical Co., Ltd.（China）
• Brainsway Ltd.（USA）
• NeuroPace Inc.（USA）
• Functional Neuromodulation Ltd.（USA）
• NeuroSigma, Inc.（USA）
• Beijing Pinchi Medical Equipment Co., Ltd.（China）
• SceneRay Corporation Ltd.（China）
• Sapiens Steering Brain Stimulation（Netherlands）
• Renishaw plc（UK）
• Synapse Biomedical Inc.（USA）
• Deep Brain Innovations LLC（USA）
• Newronika SpA（Italy）
• Nexstim Plc（Finland）
• Neuronetics, Inc.（USA）
• Magstim Company Limited（UK）
• Bioinduction Ltd.（UK）

結論和建議

Global Deep Brain Stimulation Devices Market size was valued at USD 1.54 billion in 2023 and is poised to grow from USD 1.68 billion in 2024 to USD 3.4 billion by 2032, growing at a CAGR of 9.2% during the forecast period (2025-2032).

The global deep brain stimulation (DBS) device market is experiencing robust growth, driven by the rising incidence of neurological disorders such as Parkinson's disease and essential tremor, which has intensified the demand for effective treatment solutions. Advances in DBS technology, including longer-lasting rechargeable devices and improved targeting systems, have enhanced procedural efficacy and safety. Increased acceptance of DBS as a credible treatment, along with heightened awareness among patients and healthcare professionals, contributes significantly to market expansion. Favorable reimbursement policies in developed regions and escalating healthcare investments in emerging markets are further propelling growth opportunities for manufacturers. Overall, the convergence of these factors positions the DBS device market for substantial advancement in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Deep Brain Stimulation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Deep Brain Stimulation Devices Market Segments Analysis

Global Deep Brain Stimulation Devices Market is segmented by Product Type, Application, End User and region. Based on Product Type, the market is segmented into Single-channel DBS Devices and Dual-channel DBS Devices. Based on Application, the market is segmented into Epilepsy, Pain Management, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinson's Disease, Depression, Dystonia and Others. Based on End User, the market is segmented into Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Deep Brain Stimulation Devices Market

The Global Deep Brain Stimulation Devices market is primarily driven by innovations in technology that have markedly enhanced patient outcomes and broadened the array of conditions that can be effectively treated. Key advancements include the creation of highly accurate targeting systems and refined stimulation parameters, alongside the incorporation of sophisticated features like closed-loop systems and adaptive algorithms. These technological improvements facilitate personalized treatment regimens, optimize symptom management, and lessen potential side effects, thereby strengthening the overall efficacy and safety of deep brain stimulation therapy. As a result, the market is experiencing robust growth fueled by these transformative developments.

Restraints in the Global Deep Brain Stimulation Devices Market

The global deep brain stimulation devices market faces significant restraints primarily due to the complexity of these devices, which necessitate precise implantation surgeries conducted by highly skilled neurosurgeons. The overall expenses associated with these devices-encompassing the hardware, leads, and programming systems-can be quite high. Furthermore, the costs associated with the surgical procedure increase as they require specialized equipment, operating room facilities, and extensive post-operative care. This high financial burden presents a barrier to affordability and accessibility, particularly in regions where healthcare resources are scarce or insurance coverage is insufficient, limiting the market's potential growth.

Market Trends of the Global Deep Brain Stimulation Devices Market

The Global Deep Brain Stimulation (DBS) Devices market is witnessing significant growth, largely fueled by the rising prevalence of neurological disorders, particularly among the aging population. Conditions such as Parkinson's disease, essential tremor, and dystonia are becoming increasingly common due to factors like chronic disease proliferation and exposure to environmental toxins. As awareness about DBS as a highly effective treatment option spreads, there is a marked increase in demand for these devices. This trend underscores a shifting focus towards innovative surgical interventions in neurology, positioning the DBS market for robust expansion in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Regulatory Analysis

Global Deep Brain Stimulation Devices Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Single-channel DBS Devices
• Dual-channel DBS Devices

Global Deep Brain Stimulation Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Epilepsy
• Pain Management
• Essential Tremor
• Obsessive Compulsive Disorder (OCD)
• Parkinson's Disease
• Depression
• Dystonia
• Others

Global Deep Brain Stimulation Devices Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Neurology Clinics
• Ambulatory Surgical Centers
• Research Centers
• Others

Global Deep Brain Stimulation Devices Market Size & CAGR (2025-2032)

• North America (Product Type, Application, End User)
  • US
  • Canada
• Europe (Product Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic Plc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aleva Neurotherapeutics S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing PINS Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brainsway Ltd. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroPace Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Functional Neuromodulation Ltd. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroSigma, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing Pinchi Medical Equipment Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SceneRay Corporation Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sapiens Steering Brain Stimulation (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Renishaw plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synapse Biomedical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Deep Brain Innovations LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Newronika S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nexstim Plc (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuronetics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Magstim Company Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioinduction Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations